Pharmacological management of fibromyalgia: a Bayesian network meta-analysis.
Filippo MiglioriniNikolaos MalliaropoulosJörg EschweilerMatthias KnobeMarkus TingartGiorgia ColarossiPublished in: Expert review of clinical pharmacology (2022)
According to published evidence, pregabalin, and duloxetine evidenced the greatest improvement of the FIQ and SF36 Physical and Mental subscales, along with the lowest rate of adverse events leading to study discontinuation. The results must be interpreted in light of possible adverse events associated with the use of these drugs.